GSK partners with Government on quadrivalent flu jab


flu virus in pink

GSK Australia is partnering with the Australian Government to provide a quadrivalent influenza vaccine for the National Immunisation Program for the 2016 season.

Fluarix® Tetra is a four-strain flu vaccine indicated for the active immunisation of adults and children from three years of age for the prevention of influenza disease caused by the influenza virus types A and B contained in the vaccine.

Most flu vaccines today contain three strains of flu. Four-strain flu vaccines include an additional B strain of influenza.

Dr Andrew Weekes, Medical Director at GSK, says: “GSK is delighted to be making this four-strain influenza vaccine available for the National Immunisation Program in Australia.

“The vaccine contains inactivated A and B virus strains, which can help reduce the likelihood of catching any of four different strains of seasonal flu.”

 

Previous New survey identifies real food poisoning culprits
Next Hunt for dementia genes awarded Government funding

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.